Hemato Oncologos S.A. ( Site 1065)
Cali, Valle Del Cauca, Colombia
Cancer treatment center in Cali
Calle 5B5 #38 -10, San Fernando, Cali, Valle del Cauca
About Hemato Oncologos S.A. ( Site 1065)
"HEMATO ONCÓLOGOS, Instituto de Oncología, es una Institución prestadora de Servicios de Salud especializados en Hematología y Oncología con más de 20 años de experiencia, cuya filosofía es ofrecer atención integral a los pacientes, bajo la premisa de que es posible vivir con bienestar personal, familiar, laboral durante y después del cáncer. También se realizan pruebas COVID. Teléfono: 5184303"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hemato Oncologos S.A. ( Site 1065)
During the past decade, Hemato Oncologos S.A. ( Site 1065) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
2002-04-01
2014-02-01
Completed
58
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
2002-05-01
2014-06-01
Completed
3,871
S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer
2002-11-01
2009-12-01
Completed
671
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
2002-12-01
2016-12-01
Completed
546
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-11-03
2025-12-01
Active, not recruiting
2,672
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
2003-08-01
2016-12-01
Completed
1,706
S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
2003-11-01
2027-01-01
Active, not recruiting
3,294
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hemato Oncologos S.A. ( Site 1065)"
#1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Hemato Oncologos S.A. ( Site 1065)
According to Clinical.Site data, the most researched conditions in "Hemato Oncologos S.A. ( Site 1065)" are
"Prostatic Neoplasms" (2 trials), "Basal Cell Carcinoma" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Hemato Oncologos S.A. ( Site 1065)" in a lesser frequency.
Clinical Trials Intervention Types at Hemato Oncologos S.A. ( Site 1065)
Most popular intervention types in "Hemato Oncologos S.A. ( Site 1065)" are "Drug" (4 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Docetaxel" (2 trials), "Pembrolizumab" (2 trials), "Placebo" (2 trials), "Avelumab" (1 trials) and "Dexamethasone" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hemato Oncologos S.A. ( Site 1065)
The vast majority of trials in "Hemato Oncologos S.A. ( Site 1065)" are
2 trials for "All" genders and 2 trials for "Male" genders.
Clinical Trials Status at Hemato Oncologos S.A. ( Site 1065)
Currently, there are NaN active trials in "Hemato Oncologos S.A. ( Site 1065)".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Hemato Oncologos S.A. ( Site 1065),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hemato Oncologos S.A. ( Site 1065), 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".